Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine-Associated Brain Changes: A Review of the Neuroimaging Literature
Dawn F. Ionescu, Julia M. Felicione, Aishwarya Gosai, et al.
Harvard Review of Psychiatry (2018) Vol. 26, Iss. 6, pp. 320-339
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Rebecca B. Price, Ronald S. Duman
Molecular Psychiatry (2019) Vol. 25, Iss. 3, pp. 530-543
Open Access | Times Cited: 468
Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review
Patricio Molero, Josep Antoni Ramos‐Quiroga, Rocío Martín‐Santos, et al.
CNS Drugs (2018) Vol. 32, Iss. 5, pp. 411-420
Closed Access | Times Cited: 217
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkers
Dmitriy Matveychuk, Rejish K. Thomas, Jennifer Swainson, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 160
The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Gerard Sanacora, Zhen Yan, Maurizio Popoli
Nature reviews. Neuroscience (2021) Vol. 23, Iss. 2, pp. 86-103
Closed Access | Times Cited: 125
New and emerging approaches to treat psychiatric disorders
Katherine W. Scangos, Matthew W. State, Andrew H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 317-333
Closed Access | Times Cited: 70
Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms
Samuel Kohtala
Pharmacological Reports (2021) Vol. 73, Iss. 2, pp. 323-345
Open Access | Times Cited: 90
Over-activation of primate subgenual cingulate cortex enhances the cardiovascular, behavioral and neural responses to threat
Laith Alexander, Christian M. Wood, Philip Gaskin, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 84
A Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
Neil K. Savalia, Ling-Xiao Shao, Alex C. Kwan
Trends in Neurosciences (2020) Vol. 44, Iss. 4, pp. 260-275
Open Access | Times Cited: 81
The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research
Meysam Amidfar, Marie Woelfer, Gislaine Z. Réus, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 94, pp. 109668-109668
Closed Access | Times Cited: 75
Subacute effects of the psychedelic ayahuasca on the salience and default mode networks
Lorenzo Pasquini, Fernanda Palhano-Fontes, Dráulio Barros de Araújo
Journal of Psychopharmacology (2020) Vol. 34, Iss. 6, pp. 623-635
Open Access | Times Cited: 74
Ketamine treatment for refractory anxiety: A systematic review
Jamie L. Tully, Amelia D. Dahlén, Connor J. Haggarty, et al.
British Journal of Clinical Pharmacology (2022) Vol. 88, Iss. 10, pp. 4412-4426
Open Access | Times Cited: 60
Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2
Juan Pablo López, Malte Lücken, Elena Brivio, et al.
Neuron (2022) Vol. 110, Iss. 14, pp. 2283-2298.e9
Open Access | Times Cited: 59
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review
David S. Mathai, Matthew J. Meyer, Eric A. Storch, et al.
Journal of Affective Disorders (2019) Vol. 264, pp. 123-129
Closed Access | Times Cited: 72
Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents
Molly C. Kalmoe, Alvin M. Janski, Charles F. Zorumski, et al.
Journal of the Neurological Sciences (2020) Vol. 412, pp. 116778-116778
Open Access | Times Cited: 59
Functional connectivity between prefrontal cortex and subgenual cingulate predicts antidepressant effects of ketamine
Matti Gärtner, Sabine Aust, Malek Bajbouj, et al.
European Neuropsychopharmacology (2019) Vol. 29, Iss. 4, pp. 501-508
Open Access | Times Cited: 56
Ketamine-induced changes in plasma brain-derived neurotrophic factor (BDNF) levels are associated with the resting-state functional connectivity of the prefrontal cortex
Marie Woelfer, Meng Li, Lejla Čolić, et al.
The World Journal of Biological Psychiatry (2019) Vol. 21, Iss. 9, pp. 696-710
Closed Access | Times Cited: 55
Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial
Raphael Schiffmann, Timothy M. Cox, Jean-François Dedieu, et al.
Brain (2022) Vol. 146, Iss. 2, pp. 461-474
Open Access | Times Cited: 28
Ketamine’s rapid antidepressant effects are mediated by Ca2+-permeable AMPA receptors
Anastasiya Zaytseva, Evelina Bouckova, McKennon J Wiles, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 18
Changes in white matter microstructure following serial ketamine infusions in treatment resistant depression
Brandon Taraku, Roger P. Woods, Michael Boucher, et al.
Human Brain Mapping (2023) Vol. 44, Iss. 6, pp. 2395-2406
Open Access | Times Cited: 16
Effects of Serial Ketamine Infusions on Corticolimbic Functional Connectivity in Major Depression
Megha Vasavada, Joana Loureiro, Antoni Kubicki, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2020) Vol. 6, Iss. 7, pp. 735-744
Open Access | Times Cited: 41
Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: A long and winding road
Bashkim Kadriu, Laura Musazzi, Jenessa N. Johnston, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 12, pp. 2816-2838
Open Access | Times Cited: 39
Convergence of distinct signaling pathways on synaptic scaling to trigger rapid antidepressant action
Kanzo Suzuki, Ji‐Woon Kim, E. D. Nosyreva, et al.
Cell Reports (2021) Vol. 37, Iss. 5, pp. 109918-109918
Open Access | Times Cited: 35
Reward processing as a common diathesis for chronic pain and depression
Sakina J. Rizvi, Wiebke Gandhi, Tim V. Salomons
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 749-760
Open Access | Times Cited: 34
The evolutionary old forebrain as site of action to develop new psychotropic drugs
A.J.M. Loonen, Svetlana А. Ivanova
Journal of Psychopharmacology (2018) Vol. 32, Iss. 12, pp. 1277-1285
Open Access | Times Cited: 38
Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
Ana María Rivas-Grajales, Ramiro Salas, Meghan E. Robinson, et al.
The International Journal of Neuropsychopharmacology (2020) Vol. 24, Iss. 5, pp. 383-391
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top